BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, January 9, 2025
See today's BioWorld MedTech
Home
» Rising med-tech deal volume and M&A values propelled by digital health
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Rising med-tech deal volume and M&A values propelled by digital health
Sep. 19, 2022
By
Karen Carey
No Comments
The number of med-tech deals in 2022 are up by 18% over last year, and the value of mergers and acquisitions has climbed 11%.
BioWorld MedTech
Analysis and data insight
Deals and M&A
